October 21st 2024
The Global Organization for EPA and DHA Omega-3s’ vice president of regulatory and scientific affairs talks about recent class actions and why they are without merit.
Nutritional Outlook’s 2019 Best of the Industry Award Winners
December 3rd 2019In Nutritional Outlook's 2019 Best of the Industry Awards, we are recognizing individuals, groups, and companies whose initiatives today may help shape, for the better, the state of the dietary supplement and food and beverage industries for years to come.
Leading nutritionist for Futbol Club Barcelona will be closing keynote at GOED Exchange 2020
November 18th 2019The leading nutritionist from the renowned Futbol Club Barcelona, Maria Antonia Lizarraga Dallo, MD, will be the closing keynote speaker at the GOED Exchange 2020 taking place February 4-6, 2020 in Barcelona, Spain.
Natures Crops International and Braini LLC announce global Ahiflower supply agreement
October 28th 2019Natures Crops International has entered into a global supply agreement with Braini LLC for its branded Ahiflower oil (NeurXcel) which will be incorporated into the Braini memory and cognitive health platform slated for launch in December of 2019.
Recent study on the effects of omega-3s on preterm birth encourage further investigation
September 16th 2019Results of the recently published Omega-3 to Reduce the Incidence of Preterm Birth (ORIP) trial showed that supplementation with omega-3 long chain polyunsaturated fatty acids did not lower risk of early preterm delivery. This is leading the researchers to believe a more targeted approach may be necessary.
Amarin Pharma petitions Supreme Court to review lower court decision on omega-3 supplements
July 31st 2019Amarin Pharma has filed a petition for certiorari asking the Supreme Court to review a decision made by the U.S. Court of Appeals for the Federal Circuit to uphold a 2017 decision of the International Trade Commission (ITC) not to investigate Amarin’s complaints against manufacturers of omega-3 EPA concentrates.
Aker BioMarine secures new patent for Flexitech technology
July 23rd 2019The United States Patent and Trademark Office granted the Aker BioMarine's patent application 15/040,330, which covers Aker’s Flexitech technology, used to make Superba 2 and Superba Boost krill oil products at its Houston facility.
Amarin will file citizen petition to FDA asserting ethyl ester omega-3s are not legally supplements
July 17th 2019In comments submitted to FDA, Amarin Pharma, maker of the omega-3 drug Vascepa, stated its intentions to file a citizen petition to FDA asserting that ethyl ester omega-3s are not legally allowed to be marketed as dietary supplements.
Cognizin citicoline and DHA combo may improve learning, memory after stroke
June 6th 2019In a new animal study, researchers tested the effects of a supplement combination of Kyowa Hakko’s Cognizin-brand citicoline and omega-3 fatty acid DHA (DSM’s life’sDHA brand) in mice who were subjected to bilateral common carotid artery occlusion, resulting in cerebral ischemia.
Amarin settles lawsuits with Coromega and Omax Health
May 9th 2019Amarin Pharma Inc., maker of high-concentration EPA-only omega-3 drug Vascepa, has reached a settlement with omega-3 dietary supplement companies The Coromega Company, Inc., and Omax Health, Inc over complaints the drug company filed in October of 2018.